In multiple myeloma (MM) (Table 4), Barbareulo showed that c-Jun N-terminal kinase 2 (JNK2) constitutively suppresses JNK1-mediated apoptosis by affecting expression of PARP14. Here, MAPK9 is linked to plasma cell myeloma.